CORRECTION article

Front. Pharmacol., 05 March 2019

Sec. Drugs Outcomes Research and Policies

Volume 10 - 2019 | https://doi.org/10.3389/fphar.2019.00129

Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy

  • 1. Centre for Research on Health and Social Care Management (CERGAS) SDA Bocconi School of Management, Milan, Italy

  • 2. Department of Social and Political Sciences, Bocconi University, Milan, Italy

  • 3. Federchimica Assosalute, Milan, Italy

  • 4. Department of Pharmaceutical Sciences, Università del Piemonte Orientale, Novara, Italy

In the original article, there was a mistake in Table 2 as published. The item “NON prescription (C and Cbis)”, should have been listed as “NON prescription (C)”. Additionally, there was a mistake in Figure 1 as published. The horizontal axis interval was incorrect, therefore rendering the labels ineligible. The corrected Table 2 and Figure 1 appears below.

Table 2

ItemsSwitchable marketOverall market 2015%
Volumes (thousands of units)133,5671,662,8008.0%
Reimbursed prescription only (A)95,9651,336,5237.2%
NON Reimbursed prescription only (C)24,529251,4829.8%
NON prescription (C)13,07374,79517.5%
Expenditure (million Euro)1,67715,97910.5%
Reimbursed prescription only (A)1,19812,2959.7%
NON Reimbursed prescription only (C)3163,03810.4%
NON prescription (C)16264625.1%

Market of switchable drugs (2015).

Source: own elaboration on IQVIA data.

Figure 1

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Summary

Keywords

switch, OTC, economic impact, self-medication, pharmaceutical expenditure

Citation

Otto MH, Pillarella C and Jommi C (2019) Corrigendum: The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy. Front. Pharmacol. 10:129. doi: 10.3389/fphar.2019.00129

Received

24 December 2018

Accepted

05 February 2019

Published

05 March 2019

Volume

10 - 2019

Edited and reviewed by

Philippe Van Wilder, Free University of Brussels, Belgium

Updates

Copyright

*Correspondence: Monica Hildegard Otto

This article was submitted to Pharmaceutical Medicine and Outcomes Research, a section of the journal Frontiers in Pharmacology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics